Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 15;62(16):2450-2460.
doi: 10.1021/acs.biochem.3c00258. Epub 2023 Jul 24.

2'-Deoxy Guanosine Nucleotides Alter the Biochemical Properties of Ras

Affiliations

2'-Deoxy Guanosine Nucleotides Alter the Biochemical Properties of Ras

Sangho D Yun et al. Biochemistry. .

Abstract

Ras proteins in the mitogen-activated protein kinase (MAPK) signaling pathway represent one of the most frequently mutated oncogenes in cancer. Ras binds guanosine nucleotides and cycles between active (GTP) and inactive (GDP) conformations to regulate the MAPK signaling pathway. Guanosine and other nucleotides exist in cells as either 2'-hydroxy or 2'-deoxy forms, and imbalances in the deoxyribonucleotide triphosphate pool have been associated with different diseases, such as diabetes, obesity, and cancer. However, the biochemical properties of Ras bound to dGNP are not well understood. Herein, we use native mass spectrometry to monitor the intrinsic GTPase activity of H-Ras and N-Ras oncogenic mutants, revealing that the rate of 2'-deoxy guanosine triphosphate (dGTP) hydrolysis differs compared to the hydroxylated form, in some cases by seven-fold. Moreover, K-Ras expressed from HEK293 cells exhibited a higher than anticipated abundance of dGNP, despite the low abundance of dGNP in cells. Additionally, the GTPase and dGTPase activity of K-RasG12C was found to be accelerated by 10.2- and 3.8-fold in the presence of small molecule covalent inhibitors, which may open opportunities for the development of Pan-Ras inhibitors. The molecular assemblies formed between H-Ras and N-Ras, including mutant forms, with the catalytic domain of SOS (SOScat) were also investigated. The results show that the different mutants of H-Ras and N-Ras not only engage SOScat differently, but these assemblies are also dependent on the form of guanosine triphosphate bound to Ras. These findings bring to the forefront a new perspective on the nucleotide-dependent biochemical properties of Ras that may have implications for the activation of the MAPK signaling pathway and Ras-driven cancers.

PubMed Disclaimer

Conflict of interest statement

The authors declare no potential conflicts of interest

Disclosure of Potential Conflicts of Interests

No potential conflicts of interest were disclosed.

Figures

Figure 1.
Figure 1.. Recombinant H- and N-Ras proteins co-purify with different guanosine nucleotides.
(A) Native mass spectrum of H-Ras in 200 mM ammonium acetate (pH 7.4). (B) Deconvolution of the mass spectrum shown in panel A. Different nucleotide bound Ras species are labeled. Asterisks denote sodium and/or magnesium bound adducts. (C) Mole fraction of 2’-deoxy guanosine di- and triphosphate bound to H-Ras and oncogenic mutants. (D) Mole fractions of 2’-hydroxy guanosine di- and triphosphate bound to H-Ras and oncogenic mutants. (E) Mole fraction of 2’-deoxy guanosine di- and triphosphate bound to N-Ras and oncogenic mutants. (F) Mole fractions of 2’-hydroxy guanosine di- and triphosphate bound to N-Ras and oncogenic mutants. Reported is the abundance from one measurement.
Figure 2.
Figure 2.. Native mass spectra reveal different guanosine nucleotides co-purifiy with K-Ras proteins purified from HEK293 cells.
(A) Deconvolution of K-RasWT expressed from HEK293 cells in 200 mM ammonium acetate (pH 7.4). (B) Deconvolution of K-RasG12C expressed from HEK293 cells in 200 mM ammonium acetate (pH 7.4). Different nucleotide bound K-Ras species are labeled. Asterisks denote sodium and/or magnesium bound adducts. (C) Mole fraction of 2’-deoxy guanosine di- and triphosphate bound to K-Ras and the oncogenic mutant. (D) Mole fraction of 2’-hydroxy guanosine di- and triphosphate bound to K-Ras and the oncogenic mutant. Reported is the abundance from one measurement.
Figure 3.
Figure 3.. Intrinsic GTP and dGTP Hydrolysis rates of H-Ras, N-Ras, and their oncogenic mutants.
A-B) Intrinsic hydrolysis rates of GTP (green) and dGTP (blue) were determined at 25°C for A) H-Ras and B) N-Ras proteins. Reported are the mean and standard deviation (n=3).
Figure 4.
Figure 4.. Impact of K-RasG12C inhibitors on the intrinsic GTPase activity of K-Ras protein.
(A-B) The percentage of GTP-bound K-Ras proteins plotted over time (dots) and fit to a first-order rate constant model (line) in the presence/absence of K-RasG12C inhibitors. (C) Correlation plot of drug bound K-RasG12C vs 1-[GTP bound] K-RasG12C. R2 for linear fit (Sotorasib) is 0.99 and R2 for linear fit (Adagrasib) is 0.99. (D) Bar graph of the fold increase in GTP hydrolysis rate. One Asterisk denotes p-values <0.05 and two Asterisks denote p-values <0.01. Reported are the mean and standard deviation (n=3).
Figure 5.
Figure 5.. Guanosine nucleotides influence the complexes formed between H-Ras and oncogenic mutants with SOScat.
A) Mole fraction of SOScat and complexes with H-Ras and oncogenic mutants loaded with GTP. B) Shown as described for C but with H-Ras proteins loaded with dGTP. C) Mole fraction of SOScat and complexes with N-Ras and oncogenic mutants loaded with GTP. D) Shown as described for E but with N-Ras proteins loaded with dGTP. Reported are the mean and standard deviation (n=3).

Similar articles

Cited by

  • Capturing RAS oligomerization on a membrane.
    Yun SD, Scott E, Chang JY, Bahramimoghaddam H, Lynn M, Lantz C, Russell DH, Laganowsky A. Yun SD, et al. Proc Natl Acad Sci U S A. 2024 Aug 20;121(34):e2405986121. doi: 10.1073/pnas.2405986121. Epub 2024 Aug 15. Proc Natl Acad Sci U S A. 2024. PMID: 39145928 Free PMC article.
  • Real time characterization of the MAPK pathway using native mass spectrometry.
    Scott E, Yun SD, Moghadamchargari Z, Bahramimoghaddam H, Chang JY, Zhang T, Zhu Y, Lyu J, Laganowsky A. Scott E, et al. Commun Biol. 2025 Apr 16;8(1):617. doi: 10.1038/s42003-025-08028-5. Commun Biol. 2025. PMID: 40240517 Free PMC article.
  • Molecular glue degrader for tumor treatment.
    Hu Y, Yan Y, Wang J, Hou J, Lin Q. Hu Y, et al. Front Oncol. 2024 Dec 12;14:1512666. doi: 10.3389/fonc.2024.1512666. eCollection 2024. Front Oncol. 2024. PMID: 39759140 Free PMC article. Review.

References

    1. Colicelli J, Human RAS superfamily proteins and related GTPases. Sci STKE 2004, 2004 (250), RE13. - PMC - PubMed
    1. Goitre L; Trapani E; Trabalzini L; Retta SF, The Ras superfamily of small GTPases: the unlocked secrets. Methods Mol Biol 2014, 1120, 1–18. - PubMed
    1. Downward J, Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 2003, 3 (1), 11–22. - PubMed
    1. Hobbs GA; Der CJ; Rossman KL, RAS isoforms and mutations in cancer at a glance. J Cell Sci 2016, 129 (7), 1287–1292. - PMC - PubMed
    1. Bryant KL; Mancias JD; Kimmelman AC; Der CJ, KRAS: feeding pancreatic cancer proliferation. Trends Biochem Sci 2014, 39 (2), 91–100. - PMC - PubMed

Publication types

MeSH terms

Substances